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Although acquired immunity to Schistosoma mansoni infection has been described in 
a  number of experimental  models (1-4),  the mechanism of such immunity has proved 
difficult to study in vivo. For many years,  attempts to transfer immunity with either 
serum  or lymphoid cells were  unsuccessful  (5,  6).  Recently,  however,  Sher et  al.  (7) 
succeeded in transferring immunity in mice with serum. Subsequent experiments in rats 
revealed  a  brief period,  2-4  wk  after  a  primary  infection,  when  immunity could be 
transferred with lymphoid cells (8), but at the peak of immunity, 6-8 wk after a primary 
infection, it was again serum that was effective in transferring resistance (8, 9). Success- 
ful transfer depended on the presence in the recipient of one or more types of radiosensi- 
tive cell  (9). 
These findings suggested that some form of antibody-dependent, cell-mediated effector 
mechanism might be involved. In an attempt to analyze this mechanism in vitro, we 
developed  (10, 11)  a  ~chromium release  technique  for estimating damage to  schisto- 
somula, the larval stage of the parasite which is found immediately ai~r the infective 
cercariae penetrate the skin of a mammalian host, and against which protective immune 
responses are most probably directed (12). With this technique, we identified an antibody- 
dependent, complement-independent release of ~lCr from labeled schistosomula induced 
by human peripheral blood leukocytes. In this system, effector cell activity was associ- 
ated with a  leukocyte fraction rich in granulocytes, in contrast to a  mononuclear-rich 
fraction  which  was  almost  inactive  (13). Effector  cell  activity  could  be  ablated  by 
pretreatment  of a  mixed  leukocyte  preparation  with  an  anti-eosinophil  serum  and 
complement, whereas an antineutrophil serum had relatively little effect. 
These results implied that the eosinophil was the major cell responsible for antibody- 
dependent damage to schistosomula, and led Mahmoud et al. (14) to test the effect of anti- 
eosinophil serum on immunity in mice. Ablation of  circulating eosinophils was associated 
with loss  of immunity,  strongly suggesting that the  eosinophil mediated  mechanism 
observed in vitro reflected events that occur in vivo. 
An alternative approach to investigating the ability of eosinophils to mediate 
antibody-dependent damage to schistosomula has now been developed. In this 
paper,  we report that populations  of cells highly enriched in  eosinophils  and 
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devoid of neutrophils mediate such damage. In contrast, populations enriched in 
mononuclear cells or neutrophils, but devoid of eosinophils, are not able to do so. 
Furthermore,  the addition of homologous lymphocytes,  monocytes,  or neutro- 
phils  from  normal  individuals  to  purified  eosinophils  does  not  enhance  the 
cytotoxic effect of these eosinophils. 
Also of interest is the finding that eosinophils from patients with S. mansoni 
were  often  less  active  cell  per  cell  than  eosinophils  from  normal  subjects. 
Whether this is partly due to a blockade of an Fc receptor on the eosinophils by 
antigen-antibody  complexes,  or  to  a  functional  heterogeneity  of eosinophils 
associated either with the influx of many immature cells into the blood of these 
patients  or with  damage to such cells  in the circulation,  remains  to be deter- 
mined. 
Materials and Methods 
Parasite Cycle and Preparation ofSchistosomula.  A local strain of S. mansoni, recovered from 
naturally infected Biomphalaria pfeifferi, was maintained by passage in laboratory-bred snails 
and CBA mice, as described elsewhere (15). Schistesomula were prepared by allowing cercariae to 
penetrate an isolated preparation of mouse skin in vitro (16).  The organisms recovered,  which 
were contaminated with not more than 5-10% cercariae, were stored overnight at 4°C in Hank's 
balanced salt solution, pH 7.4, containing 0.5% lactalbumin hydrolysate, 100 U/ml penicillin, and 
100 ~g/ml streptomycin, together with 10% heat-inactivated fetal calf serum (FCS). 
After overnight storage,  schistosomula were labeled with 5~Cr sodium chromate  (The Radi- 
ochemical  Centre,  Amersham,  England),  1,000  ~Ci/104 organisms,  for 3-4 h  at  37°C.  Labeled 
organisms were washed four times in Eagle's minimal essential medium (MEM) containing 20 mM 
Hepes, 100 U/ml penicillin, and 100 ~g/ml streptomycin, and twice in MEM containing 10% heat- 
inactivated fetal calf serum (MEM/FCS). ~ After checking that the final wash contained <0.5% of 
the total counts present in the schistosomula, the organisms were resuspended in MEM/FCS at 
500/ml. Such preparations routinely showed a count rate of about 100 cps in an aliquot containing 
50 schistosomula. 
Antisera.  Serum samples were obtained from patients with S. mansoni  infection, and were 
inactivated at 56°C  for  1 h  before testing for their ability to induce release of chromium from 
labeled schistosomula in the presence of unpurified normal peripheral blood leukocytes. Dilutions 
in MEM/FCS were chosen which gave high levels of cell-dependent cytotoxicity. These gave no 
direct toxicity to schistosomula. Pooled samples of human sera were used in some experiments. 
Preparation and Purification of  Effector Cells.  Peripheral blood leukocytes were prepared from 
normal individuals, from patients with eosinophilia associated with S. mansoni, with or without 
other  helminth  infections,  or  from  a  patient  with  eosinophilia  of  unknown  origin,  without 
detectable helminth infection. 5 vol of freshly-drawn, heparinized blood was allowed to sediment 
with 1 vol of 4.5% dextran in phosphate-buffered saline (Dextran 150,000; Sigma Chemical Co., St. 
Louis, Mo.) for 30 min at 37°C.  The leukocyte-rich supernate was withdrawn and washed twice in 
MEM by centrifugation at 1,000 rpm to remove platelets. 
Such  unpurified  preparations  either  were  tested  directly  for  cytotoxicity  after  appropriate 
dilution in MEM/FCS, or were subjected to further purification. Eosinophil-rich and eosinophil- 
depleted preparations were obtained by taking the pellet and interface, respectively, after centrif- 
ugation for 40 min at 400 g  and 4°C over diatrizoate (Hypaque 50, Winthrop Laboratories, New 
York) diluted 1:1.7  with distilled water according to Mahmoud et al.  (17). 
It should be noted that the number of neutrophils present in the various Hypaque  gradient 
fractions depends on the way that the cells are treated before they are centrifuged on the Hypaque 
cushion.  When  leukocytes  are  sedimented  in  dextran,  washed,  and  then  placed  directly  on 
Hypaque  at high cell concentrations, the cells obtained,  either from the interface or from the 
pellet, are essentially devoid of neutrophils. A small visible clump forms by the interface and it is 
removed by suction with a  water vacuum apparatus.  Presumably,  the neutrophils are in this 
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clump. On the other hand, if the cells are first centrifuged on Ficoll (Pharmacia Fine Chemicals 
Inc., Piscataway, N. J.)-metrizoate (Nyegaard) and the granulocyte-rich cells are recentrifuged on 
Hypaque at lower cell concentrations, neutrophils are found both in the interface and in the pellet 
while the eosinophils are present almost exclusively in the pellet.  Thus,  granulocyte-enriched 
preparations were obtained by taking the pellet after centrifugation of unpurified cells for 20-40 
min at 400 g  over a Ficoll-metrizoate mixture (Ficoll, 6.35 g/100 ml, and metrizoate, 10 g/100 ml in 
distilled water) according to B6yum (18).  After washing, granulocyte-enriched preparations were 
then enriched in or depleted of eosinophils by centrifugation over Hypaque, as above, followed by 
recovery of the pellet and interface, respectively. 
Purified lymphocyte preparations were obtained by taking the mononuclear-rich interface after 
centrifugation on Ficoll-metrizoate,  as above, and removing the phagocytic and adherent cells 
with carbonyl iron and a magnet. In some experiments, the cells from the interface after Hypaque 
centrifugation of buffy coat  cells  were  used  without  carbenyl iron extraction  as  preparations 
enriched in both lymphocytes and monocytes. 
Partially purified cells prepared in this way were washed twice in MEM.  Some preparations 
were then tested directly for cytotoxicity,  after appropriate dilution in MEM/FCS.  Others were 
cultured overnight in MEM/FCS at 1-2 ×  106/ml in Falcon tissue culture flasks (Biocult Laborato- 
ries). Others were treated with trypsin (trypsin-TPCK, Worthington Biochemical Corp., Freehold, 
N. J.), 10 or 1 mg/ml, in Hank's balanced salt solution for 1 h at 37°C with frequent mixing. They 
were then washed twice in MEM before overnight culture in MEM/FCS. After culture, cells were 
removed from the flask by gentle,  repeated aspiration into a  Pasteur  pipette;  they were then 
washed once in MEM, and resuspended in MEM/FCS. 
At various stages during and at the end of preparation, total leukocyte counts were carried out 
with the aid of a  Coulter counter (Coulter Electronics Inc.,  Hialeah,  Fla.). Absolute eosinophil 
counts  were  done,  with  Discombe's fluid,  and differential counts were  carried  out on Jenner- 
Giemsa-stained smears on 1,000 cells. 
Cytotoxicity Assay.  The  cytotoxicity assay has been described in detail elsewhere  (10,  11). 
Briefly,  aliquots  of 0.1  ml  of schistosomula  (500/ml)  were  dispensed  into  38  x  7-mm  round- 
bottomed plastic tubes (LP/2, Luckham,  Ltd.).  These tubes were then randomized to eliminate 
systematic variation during dispensing. Dilutions of antiserum (0.1 ml) and effector cells (0.1 ml) 
were added to each of four replicate tubes, and the tubes were incubated in humidified airtight 
plastic boxes at 37°C.  Control tubes received an appropriate volume of medium alone, cells and 
medium,  or antiserum and medium.  Maximum release of isotope was induced by freezing and 
thawing of mixtures of 0.1 ml schistosomula and 0.9 ml distilled water in 3-ml polystyrene tubes. 
In experiments involving more than one preparation of effector cell, 0.1-ml aliquots of each cell 
type were mixed in cytotoxicity tubes. Antibody (0.1 ml) and schistosomula (0.1  ml) were then 
added, giving a final volume of 0.4 ml. Alternatively, in other experiments, the schistosomula and 
antibody were previously mixed, and 0.1 ml of each effector cell was then added with a  10-20-min 
delay between each addition. 
At the end of the incubation period (7 or 15 h, in different experiments), the contents of each 
tube were resuspended and centrifugated at 200 g  for 5 min. One-half of the supernate was then 
withdrawn into a second tube and both tubes were counted for 5LCr in a Packard well-type gamma 
counter (Packard Instrument Co.,  Inc., Downers Grove, Ill.). The percentage of isotope release 
was calculated from the corrected count rates in both tubes, thereby avoiding the errors attributa- 
ble to variation in total count rate which occur if calculations are based on the count rate in the 
supernate alone. 
Statistical Analysis.  Results from individual experiments were tested by multifactorial analy- 
sis of variance on the logarithmically transformed percent release data  (19).  Individual means 
were then compared by Duncan's multiple range tests (20),  with error estimates derived from the 
residual mean square in the analysis of variance. In each figure or table, the geometric mean of 
four replicate tubes is given, together with an indication of the significance of their difference from 
the  appropriate  controls,  as  judged  by  multiple  range  tests.  In  addition,  where  feasible,  a 
summary is given in the legend to each table, indicating the significance of effects or interactions 
in  the  analysis of variance.  This  is  followed by a  least significant difference  CLSD")  figure, 
representing the difference required by the multiple range tests between two loge figures for a 
probability of P  <  0.05. Since this figure is logarithmic, for the sake of clarity, an indication of the 
arithmetic difference required is given in parentheses for one or two arbitrary but appropriate 
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Antibody-dependent  cell-mediated  damage to schistosomula  by purified eosino- 
phils.  Release of 51chromium from labeled  schistosomula  induced by purified or partially 
purified eosinophils (percentages for each preparation shown in parentheses). Preparations 
1-7  were  cultured  overnight  before  assay,  whereas preparations  8  and  9 were  tested 
immediately after purification.  Preparations 1-6 were from patients with S. mansoni, with 
or without additional helminth infestation.  Preparations 7-9 were from a patient with 
eosinophilia of unknown cause, with no detectable parasitic infection. Cells in preparation 1 
were trypsinized for 1 h, washed, and then cultured overnight before testing (the untrypsin- 
ized cells  from this  patient  showed  no activity).  All  cell  preparations were  tested  for 
cytetexicity to schistesomula,  with or without antibody,  at various effector to target ratios: 
only the highest ratios tested, ranging from 3,200:1 to 5,000:1, are shown in this figure.  In 
all cases, '~lCr  release in the presence of antibody differed from release with no antibody atP 
< 0.05 or less. Dose-response curves for some preparations are shown in Fig. 2. 
Results 
Cytotoxic  Activity of Eosinophil-Enriched  Cell Preparations.  Human blood 
leukocyte  preparations  highly  enriched  in  eosinophils  were  consistently  cyto- 
toxic  to  schistosomula  in  the  presence  of antibody  (see  Fig.  1).  For  reasons 
discussed  later,  some  of these  preparations  were  cultured  overnight  before 
testing. It can be seen that all but one of the cell preparations studied contained 
83-98.5% eosinophils; the remaining cells were mainly lymphocytes and mono- 
cytes which have been shown to be inactive (see next section and Ref. 13). It is of 
note that four of the  populations  studied  contained  no detectable  neutrophils, 
and three contained only 1% neutrophils.  The eosinophil-enriched preparations 
in the presence of antibody caused a  significantly greater release of 51Cr from 
labeled schistosomula than that induced by cells in the absence of antibody.  In 
evaluating the data,  it should be recalled that the maximum release of isotope 
after freeze-thawing the labeled schistosomula is not 100% but 55-68%, and that 
the schistosomulum,  in  contrast to the targets usually tested in  assays of this 
type, is a  large multicellular  organism. 
The first six preparations shown in Fig.  1 were taken from patients who had 
eosinophilia secondary to S. mansoni infection; some of these patients also had 
additional heminthic infections. The last three preparations were from a patient 
with eosinophilia of unknown  etiology. 
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FIG.  2.  Dose-response curves for six of the eosinophil-rich preparations shown in Fig.  i. 
All solid circles differ atP <  0.05 or less from the controls (i.e., release induced by cells from 
the same preparation in the absence of antibody). Least significant differences for P  <  0.05: 
preparation 2, 0.151  (+ 3.0% at 15%); preparation 3, 0.166 (+ 3.6% at 20%);  preparation 5, 
0.148 (+ 3.2% at 20%); preparation 6, 0.174 (+ 4.8% at 25%); preparation 8, 0.176 (+ 3.8% at 
20%);  preparation 9, 0.120 (+ 5.1% at 40%). 
ent ratios of cells to schistosomula for six of the eosinophil-enriched prepara- 
tions. It can be seen that with an increasing ratio of cells to schistosomula, there 
was a progressive increase in 51Cr release in the presence of antibody. In some 
cases, significant isotope release was found with the lowest ratio tested. Anti- 
body in the absence of cells had no effect when compared with medium alone nor 
did the highest ratio of cells without antibody. 
Lack of Cytotoxicity  by Preparations  Depleted  of Eosinophils.  The studies 
described above clearly showed that cell preparations enriched in eosinophils 
and depleted of neutrophils were capable of mediating antibody-dependent cell 
damage to schistosomula. It was therefore of interest to test whether or not cell 
preparations depleted of eosinophils were active. In two experiments, the cells 
from patients with S.  mansoni-induced  eosinophilia which sedimented at the 
interface after Hypaque centrifugation were assayed for cytotoxicity after over- 
night culture, at the same time as the eosinophil-enriched pellet. The interface 
preparations contained less than 0.1%  eosinophils, and more than 99%  of the 
cells were lymphocytes  or monocytes. As is shown in Table I, these cells were not 
cytotoxic for schistosomula in the presence of antibody. In contrast, the eosino- 
phil-rich pellet cells were active, as described in the previous section. In sepa- 
rate  experiments  (Table III,  discussed later),  it was also observed that fresh 
lymphocytes from normal individuals had little or no capacity to damage schis- 
tosomula in the presence of antibody. 
An  additional experiment was carried out to  test whether neutrophil-rich 
populations, depleted of eosinophils, were cytotoxic in this sytem. The granulo- 
cyte fraction obtained by Ficoll-metrizoate centrifugation  from a normal individ- 
ual was further centrifuged on Hypaque, as described in Methods, before testing 
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TABLE  I 
Lack of Damage to Schistosomula  by Cell Preparations Depleted of Eosinophils 
Exp.  Eosinophils  Ab 
5~Cr release 
5,000-  2,000-  500-320:1  200-100:1  No cells 
3,200:1  1,000:1 
%  % 
1  <  0.1  +  19  17  17  19  17 
-  16  18  16  15  17 
2  <  0.1  +  19  17  16  14  15 
-  16  18  19  15  19 
Preparations depleted of eosinophils were obtained by centrifugation of the leukocyte-rich super- 
nate of dextran-sedimented blood from patients with S.  mansoni infection on Hypaque.  Cells 
recovered from the interface and subsequently cultured overnight contained not more than 0.1% 
eosinophils; the remaining cells were lymphocytes and monocytes. These cells failed to induce 
antibody-dependent release of 51Cr under  conditions in  which the  eosinophil-enriched pellets 
showed significant effects at cell to schistosomulum ratios of  400:1 and 320:1, for experiments 1 and 
2,  respectively. LSD  --  0.166  (+  3.6%  at 20%) for experiment 1 and 0.178  (+  3.9%  at 20%) for 
experiment 2.  No significant differences were observed between cells with antibody and cells 
without antibody at any ratio. 
immediately against schistosomula. The cell pellet, containing 21% eosinophils 
and  75%  neutrophils,  showed significant antibody-dependent cytotoxicity at 
cell:schistosomula ratios from 3,200:1 to 100:1. In contrast, the cells from the 
interface which contained 0.5% eosinophils and 45% neutrophils were not cyto- 
toxic at the highest ratio tests, namely, 1,000:1. These experiments indicate that 
populations rich in lymphocytes, monocytes, or neutrophils,  but depleted of 
eosinophils, do not mediate antibody-dependent, cell-mediated damage to schis- 
tosomula. 
Comparison of Cytotoxicity Mediated by Cells from Normal and Eosinophilic 
Subjects.  The experiments described so far strongly suggest that eosinophils 
mediate antibody-dependent damage to schistosomula, and that populations of 
lymphocytes, monocytes, and neutrophils depleted of eosinophils do not. During 
the  course  of these  studies,  however,  we  had  noted  that  eosinophils  from 
patients with eosinophilia caused by S. mansoni appeared to be less cytotoxic, 
cell for cell, than those from normal persons. Three experiments that illustrate 
this observation are presented in Table II. In these experiments, fresh prepara- 
tions of unpurified leukocytes, collected by dextran sedimentation, were tested 
directly with schistosomula.  At given cell to  schistosomula ratios,  the '~lCr 
release by cells from the normal subjects was similar to that of the cells from the 
eosinophilic subjects. If eosinophils were the only effector cell, one would have 
predicted that the populations from the subjects with eosinophilia should have 
been 10 times more effective because they contain approximately 10 times more 
eosinophils. In other words, cells from eosinophilic individuals at a ratio of 100:1 
should have induced the same isotope release as cells from normal individuals at 
a  ratio of 1,000:1. This was not the case. Furthermore, unpurified leukocytes 
from two patients with marked eosinophilia of 59 and 45% were not cytotoxic. 
One possible reason for this was that the Fc receptors of these eosinophils were 
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TABLE  II 
Antibody-Dependent,  Cell-Mediated Damage to Schistosomula.  Comparison of 
Unpurified Cells from Norma! and Eosinophilic Subjects 
%  S;Cr release 
Exp.  Source of cells  Eesinophils  Ratio cell/somula in presence  of Ab  No cells 
1,000:1  320:1  100:1  32:1  10:1 
% 
Normal  3  55  (32)  45  36  33  29  28 
S.  mansoai  47  47*  (33)  39*  36  31  30  28 
Normal  2  40  (21)  28  24  22  21  18 
S. mansoni  16  34  (21)  30  28  22  20  18 
Normal  3  62  (36)  53  46  38  37  33 
3  --  -- 
S. mansoai  44  55  (35)  47  41  39  35  33 
Freshly prepared, unpurified peripheral blood leukocytes from normal subjects and from patients with eosinophilia induced by S. 
mansoni  infection were tested for  cytotoxicity to  schistosomula at  various effector  to  target  ratios with or  without antibody over 15- 
h incubation periods. Numbers in  parentheses represent s~Cr  release of  cells  at  1,000:1  with no antibody. Values that  are  underlined 
differ  from these at  P  <  0.05. (*) Refers to paired values that differ  from each other at  P  <  0.05 or less in patient 1. 
Statistical  summary: Experiment 1. Ratio effect  P < 0.001 (F = 51.1;  5 and 36  degrees of  freedom). Effect of  cell  sourceP < 0.05 (F 
5.1; 1 and 36 df).  LSD  = 0.118 (+ 3.8% at  30%, + 6.3% at  50%). Experiment 2. Ratio effect  P  < 0.001 (F = 44.5;  6 and 37 dr).  LSD  = 
0.147 (+ 3.2% at 20%, + 6.3% at  40%). Neither cell  effect  nor cell  with ratio interaction significant.  Experiment 3. Ratio effect  P  < 
0.05 (F = 2.49;  6 and 40  df).  Ratio effect  P <:  0.001 (F = 39.9;  6 and 40  df).  LSD = 0.139 (+ 6.0% at  40%, + 8.9% at  60%). Freezing and 
thawing of  cells  in experiments 1-3 released in S~Cr: 59, 59, and 66. 
if this were so, eosinophils might be more active if they were trypsinized before 
testing.  In addition,  to  allow recovery from the  enzyme treatment, we also 
planned to incubate the cells overnight in culture medium with FCS, a proce- 
dure which itself would encourage shedding of complexes. 
The eosinophil-enriched  population of one patient was incubated in 1% trypsin 
for 1 h, washed, and then cultured overnight. The results (patient 1, Table I) 
show that these cells mediated antibody-dependent cytotoxicity. An aliquot of 
the same cells cultured overnight, but not trypsinized, was not active. However, 
in similar experiments with cells from the next two patients, the cells that were 
simply cultured overnight were cytotoxic, whereas those that were trypsinized 
were not.  We cannot explain the dramatic effect of trypsin in the first case, 
although it could have been attributable to a higher affinity of the Fc receptor 
for the particular complexes circulating in that patient. The occasional finding 
that eosinophil-enriched cells from patients with eosinophilia do not mediate 
antibody-dependent damage at the highest cell:schistosomula ratio  (5,000:1), 
whereas others do  at 32:1, suggests that the function of eosinophils may be 
altered by the patient's condition, or that eosinophils are a heterogenous  popula- 
tion. 
A problem in these experiments was that we could not assess the function of 
eosinophils from the same patient immediately after collection and also after 
overnight culture because of technical difficulties associated with availability of 
parasites and accessibility of patients. Therefore, in all experiments, the puri- 
fied cell populations were cultured overnight, except for preparations 8 and 9, 
from a  patient with eosinophilia without S.  mansoni  infection, which were 
tested on the same day they were collected and purified. 
Eosinophil-Mediated Damage to Schistosomula not Enhanced by the Addi- 
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out to investigate further the finding that eosinophfls from patients with S. 
mansoni were less active, cell for cell, than normal eosinophils. This might be 
partly explained if the patients lacked cells which themselves did not mediate 
cytotoxicity but which could act synergistically with eosinophils and enhance 
their  cytotoxicity.  Fresh  purified preparations  containing 97-99.5%  lympho- 
cytes, or neutrophil-enriched, eosinophil-depleted preparations, were obtained 
from normal subjects (see Methods). These were added to eosinophil-enriched 
preparations obtained from patients with S.  mansoni and cultured overnight. 
Data from three experiments are summarized in Table HI. In experiments 1 and 
2, it can be seen from the last column, in which no eosinophils were present, that 
fresh lymphocytes alone had little or no effect, even at the high lymphocyte to 
schistesomulum ratio of 3,200:1.  In contrast, eosinophils alone (top line of each 
set) showed a marked effect at ratios down to 320:1. Addition of lymphocytes at 
3,200:1 to varying ratios of eosinophils (bottom line of each set) did not enhance 
the effect of eosinophils alone. For the sake of simplification, data obtained from 
the addition of lymphocytes at lower ratios (1,000:1 down to 32:1) are not shown, 
as no enhancement was detected at these ratios either. Similarly, in experiment 
3, a fresh preparation of normal cells, containing 49% neutrophils, 50% lympho- 
cytes and monocytes, and 1% eosinophils had no direct effect on schistesomula at 
ratios of 3,200:1,  nor did it enhance the effect of a preparation containing 92% 
eosinophils. Thus, neither direct effects nor synergy could be detected with fresh 
preparations either of lymphocytes or of mixed neutrophils and mononuclear 
cells. 
Discussion 
In  previous  studies,  it  was  shown  that  antibody-dependent cell-mediated 
damage to schistosomula was ablated when the unpurified human blood leuko- 
cytes used as the effector cells were first treated with anti-eosinophil serum and 
complement, whereas treatment with antineutrophil serum had relatively little 
effect (13). This,  together with the findings that mononuclear cells were not 
active, strongly suggested that the eosinophil was the cell primarily responsible 
for mediating damage in this reaction. In this paper, we report results in which 
a more direct approach, namely, cell purification, was used to define the effector 
cell. It was found that cell populations containing up to 98%  eosinophils, and 
devoid of neutrophils,  were effective in  damaging antibody-coated schistoso- 
mula.  Cells  depleted of eosinophils,  but  rich  in  lymphocytes, monocytes, or 
neutrophils were ineffective. Additional  studies also essentially rule out the 
basophil  as  the  effector cell.  Basophils  sediment with  the  lymphocytes and 
monocytes after centrifugation on Ficoll-metrizoate; it was previously shown 
that this mononuclear-rich interface fraction, with or without subsequent re- 
moval of phagocytic cells with carbonyl iron, failed to damage antibody-coated 
schistosomula.  Moreover,  Butterworth  and  Mahmoud  (unpublished  observa- 
tions) have found that pretreatment of unpurified buffy coat preparations with a 
monospecific antibasophil serum (22) and complement did not affect subsequent 
cytotoxicity under circumstances in  which pretreatment with anti-eosinophil 
serum caused a 90% reduction in cytotoxicity. 
Experiments were carried out to test for the possible cooperative effect of other 
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TABLE  III 
Damage by Eosinophils Not Enhanced by Addition of Lymphocytes or 
Polymorphonuclear  Leukocytes  (PMNL) and Monocytes 
% 5~Cr release 
Exp.  Other cells added$  Eosinophils* (ratio/'~somula  '') 
3,200:1  1,000:1  320:1  0 
None  49  42  35  17 
Lymphocytes §  49  40  33  24 
2  None  59  46  33  25 
Lymphocytes§  53  4._55  35  27 
3  None  59  46  33  25 
PMNL +  Mond'  54  43  36  26 
*  Eosinophil-rich leukocyte preparations were obtained from a patient with S. mansoni infection 
by centrifugation of unpurified dextran-sedimented leukocytes over Hypaque. The preparations 
were cultured overnight before assay.  Final composition: experiment 1, 83% eosinophils,  17% 
mononuclear cells, no detectable neutrophils; experiments 2 and 3, 92% eosinophils, 7% mono- 
nuclear cells, 1% neutrophils. 
$  Other cells added were at ratios 3,200:1  down to 32:1. Since lesser ratios gave similar results, 
only those of the highest ratio, 3,200:1,  are given. 
§ Freshly prepared lymphocytes from a  normal individual were obtained by centrifugation of a 
dextran-sedimented  leukocyte  preparation  over Ficoll-metrizoate,  followed by  extraction  of 
interface  cells with  carbonyl  iron.  Final  composition: experiment  1,  97%  lymphocytes,  2.7% 
neutrophils,  0.3%  eosinophils; experiment 2, 99.5%  lymphocytes, 0.5%  neutrophils.  In experi- 
ment  1,  eosinophils  and  lymphocytes  were  mixed  in  the  ratios  shown,  and  schistosomula 
preincubated  with  antibody  were  then  added.  In  experiment  2,  eosinophils  were  added  to 
schistosomula with antibody, and lymphocytes were then added after a 10-20-min delay. Isotope 
release was determined after 7 h. 
II  Eosinophil-depleted, neutrophil-enriched cells were obtained by centrifuging the pellet from a 
Ficoll-metrizoate preparation of mixed normal cells over Hypaque, and recovering the interface 
(49% neutrophils,  1% eosinophils, 50% mononuclear cells). Eosinophils were added to schistoso- 
mula 10-20 min before the neutrophil-rich preparation; isotope release was determined after 7 h 
of incubation. 
Statistical summary:  Experiment 1. Interaction of eosinophil ratio with lymphocyte ratio P  < 
0.01  (F  =  2.64;  25 and  107 df); LSD =  0.152  (+  3.3%  at 20%,  +  7.4%  at 45%).  Experiment 2. 
Interaction of eosinophil ratio with lymphocyte ratio P  <  0.05  (F =  2.39; 9 and 47 df); LSD = 
0.128 (+ 3.4% at 25%,  + 6.8% at 50%). Experiment 3. Eosinophil ratio effect P  < 0.001 (F = 135; 3 
and 9 df); neutrophil ratio effect and interaction of neutrophil ratio with eosinophil ratio not 
significant; LSD =  0.174  (+  4.8% at 25%,  +  9.5%  at 40%). 
All values that are underlined differ from controls containing no eosinophils (last column) at P 
<  0.05.  There  was  no significant increase  in 5~Cr release by a  given ratio of eosinophils to 
schistosomula attributable to the addition of either the lymphocytes or the neutrophil-mononu- 
clear cell preparations. 
eosinophil-depleted  preparations  of lymphocytes,  neutrophils  and  monocytes. 
The  addition  of these  cells  did not enhance  the  cytotoxicity  of the  eosinophils. 
Indeed,  in one experiment,  the  addition  of lymphocytes  in high  concentrations 
partially  inhibited  the  effect  of eosinophils,  possibly  by  competing  for  bound 
antibody  on the schistosomula.  Thus,  no evidence  was found that  other  cells are 
involved  in an ancillary  fashion  during  the early  stages  of damage  to schistoso- 
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These studies also raise an important yet unresolved question: why is it that 
eosinophils from patients with eosinophilia induced by S. mansoni infection are 
less cytotoxic, cell per cell, than eosinophils from normal individuals? Several 
possible  reasons for this have been considered. First, such eosinophils may be 
less active because their Fc receptors are partially blocked by immune com- 
plexes which have been taken up  from the  circulation.  This  explanation is 
supported by the observations that immune complexes can elicit both local (23) 
and systemic (24, 25) eosinophilia when injected into animals; circulating im- 
mune complexes involving several antigens have been demonstrated during 
schistosome infections (26-30). Moreover, we have found that antigen-antibody 
complexes could completely  block the antibody-dependent  cell-mediated  damage 
to schistosomula induced either by unpurified buffy coat leukocytes  from normal 
subjects or by purified eosinophils from patients with eosinophilia.  2 
Another possible  explanation is that eosinophils may be heterogeneous, or 
that the different stages of maturation may have different capabilities: cells 
responding to a stimulus which induces eosinophilia may be less mature, or may 
be  altered or injured as  a  result of the stimulus.  This possibility cannot be 
excluded, especially in light of several observations (31-33) and in particular 
those of Tai and Spry (34, 35) that eosinophils from patients with eosinophilia 
induced by a variety of conditions are markedly heterogeneous, with many cells 
showing vacuolation or degranulation. Such cells may be depleted in vivo of 
some effector agent and this could be partly regenerated during the period of 
culture in vitro. 
Whereas the data reported here clearly implicates the human eosinophil as 
the effector cell in antibody-dependent cell-mediated damage to schistosomula, 
observations by others  in  different species have  implicated other cells.  For 
example, Dean et al.  have reported that antibody and complement-dependent 
damage to schistosomula may be effected by rat neutrophils (36), while in the 
guinea pig,  eosinophils adhere but do not damage schistosomula treated with 
antibody and complement (37). In an  antibody-dependent, complement inde- 
pendent system, analogous to the human system reported here, Sher has found 
that purified rat eosinophils are inactive against schistosomula and postulates 
that the neutrophil is the major effector cell of the rat 5~Cr release reaction 
(personal communication), while both  Perez  (9)  and Capron et al.  (38) have 
reported antibody-dependent, macrophage-mediated damage to schistosomula. 
In contrast to the present system, the macrophage-mediated  damage described 
by Perez involved IgG cytophilic antibody, while that described by Capron et al. 
was particularly interesting in that it involved IgE. 
These reports describe a plethora of mechanisms by which the combination of 
various cells with different antibody, with and without complement, can dam- 
age schistosomula in vitro. It is quite possible that any or all of these mecha- 
nisms could contribute to immunity to reinfection in a given species, and that 
several mechansims may be involved at different times in the same species.  An 
example of a  possible interaction between two mechanisms is the question of 
2 Butterworth, A. E., H. G. Remold, V. Houba, J. R. David, D. Franks, P. H. David, and R. F. 
Sturrock.  Antibody-dependent eosinophil-mediated damage  to  '~lCr-labeled schistosomula  of 
Schistosoma  mansoni:  mediation by IgG, and inhibition by antigen-antibody  complexes.  Manu- 
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how the eosinophils reach the site of the schistosomula in the first place. It 
would be  quite possible that  a  reaction involving mast cells and IgE would 
generate chemotactic factors of anaphylaxis (39, 40) which would in turn call 
forth the  eosinophils to  the site.  Thus,  the finding that  drugs that deplete 
animals of mast cells also abrogate immunity to reinfection is not evidence 
against the hypothesis that it is the eosinophils which are actually doing the 
damage  (41). In this context,  Sher has recently shown that  mast cells will 
adhere  to  schistosomula through complement components generated by the 
alternative  pathway  (42). This  could lead  to  the  generation of chemotactic 
factors of anaphylaxis which could attract eosinophils to the site. 
The eosinophil-mediated damage described here is likely to be of particular 
importance in the mouse, since Mahmoud et al. have shown that the reduction 
of circulating eosinophils by administration of anti-eosinophil serum abolishes 
immunity, whereas other anticell sera do not (14). Moreover, von Lichtenberg et 
al. have found an eight- to tenfold increase in eosinophils at the sites of cercarial 
challenge in the skin of immune mice in comparison to similar sites in normal 
mice  (43). Eosinophils have  also been described around schistosomula of S. 
japonicum in monkeys (44, 45). It is of interest that eosinophils do not gather at 
the site of cercarial challenge in immune mice depleted of mast cells by adminis- 
tration  of reserpine  (A.  Sher,  personal  communication). Although it  is  not 
possible to determine the mechanisms of immunity in man, nor even to state 
conclusively that immunity exists, the data presented here with human eosino- 
phils and antibody from patients with S.  mansoni,  indicate that eosinophil- 
mediated damage should be considered as a strong candidate. 
If eosinophil-mediated damage to schistosemula is an important mechanism 
of immunity in vivo, it is possible that the limiting factor in immunity is not 
simply the level of antibody, but rather a highly complex interaction between 
free  antibody,  immune complexes involving different schistosomal antigens, 
eosinophil levels, and eosinophil activity. This possibility is emphasized by the 
finding, described here, that not all eosinophils are equally active, and that 
cells from patients with schistosomiasis may be relatively inactive. Immunity 
may,  therefore,  depend at  least  partially  on the  availability  of a  sufficient 
number of active eosinophils at the site of cercarial penetration. The limitation 
of immunity by lack of sufficient numbers of eosinophils, by lack of eosinophil 
activity, or by interaction of eosinophils with immune complexes or with aggre- 
gated immunoglobulins, may explain some curious features about immunity to 
schistosomiasis, including the failure of some serum pools to transfer immunity 
in spite of containing high antibody levels (7), the failure to immunize with 
antigenic extracts in spite of the development  of antibodies (46), and the possible 
loss of immunity after treatment or self cure. All of  these procedures could entail 
a relative reduction in active eosinophils. Conversely, immunization with heter- 
ologous organisms may be successful because the organisms survive at least 
temporarily  within  the  host  (4), and  may  therefore  elicit  an  eosinophilia. 
Equally, attempts to increase eosinophil levels nonspecifically in the absence of 
circulating immune complexes might enhance the immunity conferred by natu- 
ral infection or by the passive transfer of serum. This possibility is currently 
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Summary 
After earlier observations that antibody-dependent, cell-mediated damage to 
51Cr-labeled schistosomula can be ablated by pretreatment of a mixed prepara- 
tion of human peripheral  blood leukocytes with an anti-eosinophil  serum and 
complement,  we  investigated  the  cytotoxic effects of eosinophil-enriched  cell 
preparations. 
Preparations  containing  up to  98.5%  eosinophils  and  devoid of neutrophils 
were effective in mediating antibody-dependent damage to schistosomula. Prep- 
arations enriched in mononuclear cells or in neutrophils,  and devoid of eosino- 
phils, were inactive. 
Eosinophfls from some patients with eosinophilia induced by schistosomiasis 
were less active on a  cell-to-cell basis than cells from normal individuals.  The 
possibility  that  such  cells were  initially  blocked by immune  complexes was 
considered, and it was found that reasonable cytotoxicity by purified eosinophils 
from patients with eosinophilia could be generated by overnight cultures. 
A  possible requirement  for cooperation  between eosinophils  and  other  cell 
types  was  also  studied.  Lymphocytes,  neutrophfls  and  monocytes  failed  to 
enhance eosinophil-mediated cytotoxicity. 
These results provide further evidence that the eosinophil is the only cell in 
man  responsible for antibody-dependent,  complement-independent  damage  to 
schistosomula in vitro.  Eosinophils  from individuals,  however,  differ in their 
cytotoxic potential by a  mechanism yet to be elucidated.  The possible relation- 
ship of these findings to immunity in vivo is discussed. 
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